Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie L Boyer

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Transactions of the American Clinical and Climatological Association|June 6, 2008
Genetic medicine strategies to protect against bioterrorismJulie L Boyer, Ronald G Crystal
Human Gene Therapy|March 4, 2009
Genetic delivery of bevacizumab to suppress vascular endothelial growth factor-induced high-permeability pulmonary edemaMasaki Watanabe, Julie L Boyer, Ronald G Crystal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
A RAS renaissance: emerging targeted therapies for KRAS-mutated non-small cell lung cancerNeil Vasan, Julie L Boyer, Roy S Herbst
Journal of Virology|August 21, 2002
The Epstein-Barr virus SM protein is functionally similar to ICP27 from herpes simplex virus in viral infectionsJulie L Boyer, Sankar Swaminathan, Saul J Silverstein
Accounts of Chemical Research|February 8, 2007
Evolution of organo-cyanometallate cages: supramolecular architectures and new Cs+-specific receptorsJulie L Boyer, Matthew L Kuhlman, Thomas B Rauchfuss
Cell Stem Cell|April 4, 2009
Genetic control of wayward pluripotent stem cells and their progeny after transplantationMaija Kiuru, Julie L Boyer, Timothy P O'Connor, et al.
Human Gene Therapy|March 12, 2005
Adenovirus-based genetic vaccines for biodefenseJulie L Boyer, Gary Kobinger, James M Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Targeting vascular endothelial growth factor in patients with squamous cell lung cancerPeter J Koo, Daniel Morgensztern, Julie L Boyer, et al.
The Lancet. Oncology|December 4, 2012
A step towards treating KRAS-mutant NSCLCSarah B Goldberg, Joseph Schlessinger, Julie L Boyer, et al.
Human Gene Therapy|November 25, 2003
Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigenYadi Tan, Neil R Hackett, Julie L Boyer, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Transactions of the American Clinical and Climatological Association|June 6, 2008
Genetic medicine strategies to protect against bioterrorismJulie L Boyer, Ronald G Crystal
Human Gene Therapy|March 4, 2009
Genetic delivery of bevacizumab to suppress vascular endothelial growth factor-induced high-permeability pulmonary edemaMasaki Watanabe, Julie L Boyer, Ronald G Crystal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
A RAS renaissance: emerging targeted therapies for KRAS-mutated non-small cell lung cancerNeil Vasan, Julie L Boyer, Roy S Herbst
Journal of Virology|August 21, 2002
The Epstein-Barr virus SM protein is functionally similar to ICP27 from herpes simplex virus in viral infectionsJulie L Boyer, Sankar Swaminathan, Saul J Silverstein
Accounts of Chemical Research|February 8, 2007
Evolution of organo-cyanometallate cages: supramolecular architectures and new Cs+-specific receptorsJulie L Boyer, Matthew L Kuhlman, Thomas B Rauchfuss
Cell Stem Cell|April 4, 2009
Genetic control of wayward pluripotent stem cells and their progeny after transplantationMaija Kiuru, Julie L Boyer, Timothy P O'Connor, et al.
Human Gene Therapy|March 12, 2005
Adenovirus-based genetic vaccines for biodefenseJulie L Boyer, Gary Kobinger, James M Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 23, 2012
Targeting vascular endothelial growth factor in patients with squamous cell lung cancerPeter J Koo, Daniel Morgensztern, Julie L Boyer, et al.
The Lancet. Oncology|December 4, 2012
A step towards treating KRAS-mutant NSCLCSarah B Goldberg, Joseph Schlessinger, Julie L Boyer, et al.
Human Gene Therapy|November 25, 2003
Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigenYadi Tan, Neil R Hackett, Julie L Boyer, et al.
Pageof 3